Key result
KLF6 knockdown protects against myocardial infarction by upregulating PTTG1 and inhibiting AMPK/mTOR signaling.
Why the study?
Does KLF6 knockdown ameliorate myocardial infarction in preclinical models?
Does KLF6 knockdown ameliorate myocardial infarction in preclinical models?
Answers are grounded in this paper and cite their sources.
KLF6 knockdown provides a protective effect against myocardial infarction via the PTTG1 and AMPK/mTOR pathways, offering a potential novel therapeutic target.
Our study demonstrates for the first time the role of Krüppel-like factor 6 (KLF6)/PTTG1 axis in myocardial infarction (MI). This study demonstrates the protective effect of KLF6 knockdown against MI, which is attributed to the elevation of PTTG1 expression and inhibition of the AMPK/mTOR pathway. These findings provide a novel insight into MI treatment.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question. KLF6 knockdown protects against myocardial infarction by elevating PTTG1 expression and inhibiting the AMPK/mTOR pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: